News Agency
Men's Weekly

AMP945 Combined with FOLFIRINOX Enhances Treatment Effects in model of Pancreatic Cancer

  • Written by PR Newswire

HIGHLIGHTS

  • Amplia's highly selective FAK inhibitor AMP945, when used in combination with FOLFIRINOX, enhances survival in a preclinical model of pancreatic cancer
  • FOLFIRINOX is the most widely used treatment for pancreatic cancer patients in the US, Canada and most European countries
  • This new data supports clinical studies investigating the...

Read more: AMP945 Combined with FOLFIRINOX Enhances Treatment Effects in model of Pancreatic Cancer

Australian Workplaces 2026: Why Office Furniture Stools Are Gaining Ground in Modern Design

Sydney, Australia — 2026 — As Australian workplaces continue to evolve at a rapid pace, a once-overlooked piece of furniture is stepping into the spotlight: the stool. From drafting stools in design studios to height-adjustable seating in schools and laboratories... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion